Imagion Biosystems Ltd has released a press release.
Appendix 4C and Quarterly Activities Report - March 2026
Earlier from Imagion Biosystems
- FY25 Appendix 4E and Annual Report
- Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent